Cargando…
COVID-19, impact on myeloma patients
Autores principales: | Dufour, Inès, Raedemaeker, Juliette, Andreozzi, Fabio, Verstraete, Géraldine, Bailly, Sarah, Delforge, Michel, Storms, Pauline, Jacquy, Caroline, Van de Velde, Ann, Mineur, Philippe, Lejeune, Marie, Bauwens, Deborah, Van Obbergh, Florence, Kentos, Alain, Nguyen, Jasmine, Fostier, Karel, De Weweire, Anne, Meuleman, Nathalie, Vekemans, Marie-Christiane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311114/ https://www.ncbi.nlm.nih.gov/pubmed/32577846 http://dx.doi.org/10.1007/s00277-020-04147-7 |
Ejemplares similares
-
P12: TREATMENTS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: RETROSPECTIVE CHART REVIEW OF REAL-WORLD OUTCOMES FOR STANDARD OF CARE
por: Vekemans, M-C, et al.
Publicado: (2022) -
Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice
por: Delforge, Michel, et al.
Publicado: (2022) -
Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance
por: Van Damme, Michaël, et al.
Publicado: (2016) -
A Molecular Score by Quantitative PCR as a New Prognostic Tool at Diagnosis for Chronic Lymphocytic Leukemia Patients
por: Stamatopoulos, Basile, et al.
Publicado: (2010) -
Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation
por: Fostier, Karel, et al.
Publicado: (2018)